responses to diazepam in the light/dark choice test (P Ͻ 0.01 versus vehicle) ( Fig.  4D ) and in the elevated plus-maze (P Ͻ 0.001 versus vehicle) (Fig. 4, E and F). These results indicate that the anxiolytic action of diazepam in wild-type mice does not involve interaction with ␣3 GABA A receptors.
Function of GATA Transcription
Factors in PreadipocyteAdipocyte Transition Qiang Tong, Gökhan Dalgin, Haiyan Xu, Chao-Nan Ting, Jeffrey M. Leiden, Gökhan S. Hotamisligil*
Genes that control the early stages of adipogenesis remain largely unknown. Here, we show that murine GATA-2 and GATA-3 are specifically expressed in white adipocyte precursors and that their down-regulation sets the stage for terminal differentiation. Constitutive GATA-2 and GATA-3 expression suppressed adipocyte differentiation and trapped cells at the preadipocyte stage. This effect is mediated, at least in part, through the direct suppression of peroxisome proliferator-activated receptor ␥. GATA-3-deficient embryonic stem cells exhibit an enhanced capacity to differentiate into adipocytes, and defective GATA-2 and GATA-3 expression is associated with obesity. Thus, GATA-2 and GATA-3 regulate adipocyte differentiation through molecular control of the preadipocyte-adipocyte transition.
In vertebrates, adipose tissue is critical for energy storage and release, as well as for endocrine homeostasis (1, 2) . The two general classes of fat cells in mammals, brown and white, have different functions. White adipose tissue (WAT) stores excess energy in the form of triglyceride and releases free fatty acids during caloric deficiency. Brown adipose tissue (BAT), on the other hand, can dissipate energy through thermogenesis. The The Drosophila serpent (srp) gene is critical for fat body formation (7, 8) and belongs to the GATA family of transcription factors, all of which share highly conserved zincfinger DNA binding domains and bind specifically to a consensus DNA sequence (A/T)GATA(A/G) (9 -11) . To study their potential biology in mammalian adipogenesis, we used Northern blot analysis to examine the patterns of expression of GATA genes in murine adipose tissues. Of the six GATA factors investigated, adipose expression was only evident for GATA-2 and GATA-3 ( Adipose tissue contains mature adipocytes, adipocyte precursors, and other cell types, such as vascular endothelial or smooth muscle cells and macrophages. To determine the source of GATA expression, we fractionated adipose tissue into mature adipocytes and the stromal-vascular fraction. Both GATA-2 and GATA-3 are expressed preferentially in the stromal-vascular fraction, which contains adipocyte precursors ( (22). (B) Mouse WAT was separated into mature adipocytes (AD) and the stromal-vascular fraction (PRE), as described (23) . The expression of GATA transcription factors and control genes expressed in adipocytes (adipsin and aP2) and preadipocytes (AEBP-1) are examined by Northern blot analysis. (C) 3T3-F442A cells were cultured to confluency (day 0), and adipocyte differentiation was induced. Plates of cells were collected for RNA isolation and examination of gene expression before the induction of differentiation and at 2-day intervals thereafter. Ethidium bromide (EtBr) staining was shown as a control for loading and integrity of RNA.
GATA-3 GATA-2 Vector GATA transcription factors were expressed in 3T3-F442A cells with a retroviral expression system, as described (22) , and treated with insulin (5 g/ml) for a week to stimulate differentiation. The extent of adipocyte differentiation was determined by Oil Red O staining.
their source in adipose tissue is likely to be preadipocytes. Furthermore, GATA-2 and GATA-3 mRNA expression was readily detected in pure populations of cultured 3T3-F442A preadipocytes but was down-regulated upon differentiation of these cells into adipocytes (Fig. 1C) . Identical results were also obtained in the 3T3-L1 preadipocyte cell line (13) . This differentiation-dependent down-regulation of GATA expression is not due to contact growth inhibition in confluent preadipocytes, because cells cultured in nonpermissive conditions for adipogenesis maintained expression of GATA-2 and GATA-3, even after reaching confluence.
We then hypothesized that GATA-2 and GATA-3 are potential preadipocyte markers and play important roles in the regulation of adipocyte differentiation. To test this, we constitutively expressed individual GATA factors in 3T3-F442A preadipocytes with a retroviral expression system (14) and assessed their ability to differentiate into adipocytes. Forced expression of GATA-2 and GATA-3 inhibited adipocyte differentiation of 3T3-F442A cells, as determined by Oil Red O staining of intracellular lipid droplets ( Fig. 2A) and examination of molecular markers of adipogenesis [Web fig. 2 (12) ]. The expression of PPAR␥, Glut4, the adipocyte fatty acid binding protein aP2, and adipsin was suppressed by GATA, as compared to differentiated controls, and the expression of Pref-1 (15) and AEBP-1 (16) was maintained at levels comparable to those observed in undifferentiated preadipocytes [Web fig. 2 (12)]. Thus, the GATA-expressing cells were trapped at the preadipocyte stage.
Next, we began exploring potential mechanisms of the effect of GATA factors on adipocyte differentiation. Because of the central role of PPAR␥ in adipogenesis, we examined the 0.6-kb proximal PPAR␥2 promoter region (17) and observed several potential GATA binding sites. We then tested the ability of GATA-2 or GATA-3 to directly regulate the transcriptional activity of PPAR␥2. Both GATA factors significantly suppressed (approximately fivefold) the activity of the 0.6-kb PPAR␥2 promoter (Fig.  3A) . In the same experimental setting, estrogen receptor response element-driven luciferase activity was enhanced by GATA-2, indicating the specificity of the GATA-mediated suppression of PPAR␥2 promoter (13) . The carboxyl and amino zinc fingers of GATA factors are involved in DNA binding (18) and protein-protein interactions (19) . Deletion of both zinc-finger domains abolished the suppression of PPAR␥2 promoter activity by both GATA factors (Fig. 3A) . Deletion of the carboxyl zinc finger of either GATA-2 or GATA-3 also significantly but incompletely reversed their ability to suppress PPAR␥2 promoter. A similar but smaller effect was observed upon deletion of the amino zinc finger. Thus, both zinc fingers are necessary, albeit with different potency, for the GATA factors to fully interact with and suppress the activity of PPAR␥2 promoter.
To test whether this GATA activity requires direct interaction with the PPAR␥2 promoter, we studied the proximal PPAR␥2 promoter region by deletion analysis and demonstrated that a 370 -base pair (bp) fragment (nucleotides -361 to ϩ9) retains basal promoter activity and is suppressed by GATA factors. To determine if and at which sites GATA factors interact directly with this promoter fragment, we performed deoxyribonuclease (DNase) I footprinting experiments (Fig. 3B ) combined with elecrophoretic mobility shift assays (Fig. 3C ) using recombinant GATA-2 and GATA-3 proteins (20) . DNase I footprinting revealed two GATA binding sites at positions -112 and -1. Sequence-dependent GATA binding to these sites was further demonstrated by the formation of specific DNA-protein complexes in electrophoretic mobility shift assays (Fig.  3C) . The formation of GATA protein-DNA complexes was prevented by the addition of a specific competitor DNA fragment with known GATA binding site from the mouse ␣1-globin promoter (Fig. 3C ). This complex was supershifted by specific antibodies to GATA, and glutathione S-transferase (GST) alone had no capacity to interact with the DNA targets used in these experiments, thus confirming specificity (13).
We next introduced point mutations into these two GATA binding sites within the 370-bp promoter region. These mutations completely abolished GATA binding, as demonstrated by electrophoretic mobility shift assays (Fig. 3C) . We then transfected NIH 3T3 cells with a luciferase reporter gene driven by the 370-bp PPAR␥2 promoter har- Fig. 3 . Effect of GATA-2 and GATA-3 on PPAR␥2 promoter activity. (A) A luciferase (luc) reporter construct under the control of 0.6-kb PPAR␥2 proximal promoter fragment (nucleotides Ϫ603 to ϩ62) was transfected into NIH 3T3 cells with GATA-2 or GATA-3 expression plasmids (24) . PPAR␥2 promoter activity is expressed in relation to vector controls, and the average of three independent experiments is shown. Error bars indicate standard error. (B) GATA binding to PPAR␥2 promoter determined by DNase I footprinting analysis. A 32 P-end labeled DNA fragment (nucleotides Ϫ264 to ϩ62) was incubated at 25°C with GST-GATA-2 fusion protein by using the Footprinting System (Promega, Madison, WI). The two sites of interaction are indicated by the dotted lines. (C) Interaction of GATA-2 (G2) and GATA-3 (G3) with DNA fragments containing GATA sites at Ϫ112 and Ϫ1 (nucleotides Ϫ119 to Ϫ85 and Ϫ22 to ϩ9, respectively), as shown by electrophoretic mobility shift assays (25) . For each protein-DNA reaction, specific (S) or nonspecific (N) DNA competitors were also included.
boring mutations in GATA binding sites at positions -112 and -1. The activity of the 370-bp fragment of PPAR␥2 promoter lacking both GATA-binding sites was not suppressed by GATA factors (106 versus 100% in the presence or absence of GATA). Introduction of mutations into either site, alone, was insufficient to prevent GATA-mediated suppression (13) . Thus, GATA-2 and GATA-3 bind directly to two specific sites on the proximal PPAR␥ promoter and negatively regulate its basal transcriptional activity.
To test whether the negative regulation of PPAR␥ activity is important for the GATAinduced suppression of adipocyte differentiation, we exogenously expressed PPAR␥ to rescue the inhibitory effects of GATA factors on adipocyte differentiation in 3T3-F442A cells. Coexpression of PPAR␥ with GATA-3 in 3T3-F442A cells resulted in substantial but incomplete reversal of GATA-induced suppression of adipogenesis as determined by Oil Red O staining of the cells (Fig. 4A) and by the expression of adipocyte markers such as aP2 and adipsin (Fig. 4B) . Similar results were also obtained in cells coexpressing GATA-2 and PPAR␥ (13). Thus, GATAinduced suppression of PPAR␥ activity is, at least in part, responsible for diminished differentiation capacity and defective expression of most adipogenic genes, although complete expression of the adipocyte phenotype in these cells may involve additional GATAmodulated pathways.
If GATA expression is required at the preadipocyte commitment stage, then cells lacking GATA factors might be impaired in their ability to differentiate. On the other hand, if GATA factors control the preadipocyte-adipocyte transition, the lack of GATA should result in accelerated differentiation into adipocytes. To address these possibilities directly, we examined the adipocyte differentiation capacity of the pluripotent embryonic stem (ES) cells lacking both functional copies of the GATA-3 gene (21). In vitro differentiation experiments demonstrated an enhanced capacity of the GATA-3-deficient ES cells to form mature adipocytes, in comparison to wild-type controls under minimally permissive hormonal conditions (Fig. 5A) . In three independent experiments, a substantially higher number of GATA-3 -/-embryoid bodies displayed adipogenesis, as compared to wild-type cells (50 versus 18%). Furthermore, the number of differentiated cells and the extent of adipocyte differentiation on each embryoid body were also markedly enhanced in the GATA-3 -/-ES cells (Fig. 5A ). Consistent with this extensive differentiation, the expression levels of adipocyte markers were also significantly elevated in GATA-3-deficient ES cells [Web fig. 3 (12) ]. Therefore, GATA-3 is not required for the lineage commitment of preadipocytes in culture, but instead functions as a negative regulator of the preadipocyte-to-adipocyte transition.
If a lack of GATA factors promotes adipogenesis, increased adiposity might be associated with defects in the expression and/or function of these genes. To begin to test this, Infected cells were selected with both hygromycin and puromycin treatment and differentiated into adipocytes with insulin (5 g/ml) and 0.1 M of PPAR␥ activator BRL49653 for 6 days. The extent of differentiation was revealed by (A) Oil Red O staining and (B) mRNA levels of adipocyte-specific genes (aP2, Glut4, and adipsin). For PPAR␥, arrows indicate exogenous (upper) and endogenous (lower) transcripts. we investigated the expression of GATA-2 and GATA-3 in WAT samples from several different models of murine obesity. These experiments demonstrated a severe reduction in the adipose expression of both GATA-2 and GATA-3 in four independent genetic models of obesity, including ob/ob, db/db, tub/tub, and KKA Y yellow, in comparison to matched lean littermates (Fig. 5B) . This reduced expression was specific to GATA, because AEBP-1 mRNA expression was not regulated in the obese animals and the level of the Pref-1 in adipose tissue was very low.
Our data demonstrate that GATA-2 and GATA-3 are preadipocyte genes, which act as molecular gatekeepers by controlling the transition from preadipocytes to adipocytes. Despite substantial changes in the architecture and the molecular complexity of adipose tissue, the biology of GATA factors at this site has been preserved from the fruit fly to the mouse. In higher organisms with balanced energy homeostasis, only a portion of the preadipocyte pool is used to become differentiated adipocytes. The remainder of the preadipocytes remains quiescent. Under the appropriate conditions, such as imbalance between energy intake and output, these cells differentiate into adipocytes and expand adiposity. If these control points fail, the result would be increased adiposity and, consequently, a higher tendency for obesity. The opposite will result in a loss of adiposity. Therefore, it is not surprising that the cellular machinery is equipped with molecules to control the rate and extent of transition between preadipocytes and adipocytes. The data presented here indicate that GATA factors are important regulators of this homeostatic mechanism and they may serve as targets for therapeutic intervention in diseases such as lipodystrophies and obesity.
